BTTX — Better Therapeutics Balance Sheet
0.000.00%
- $0.62m
- $8.33m
Annual balance sheet for Better Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Cash | |||
Cash and Equivalents | |||
Cash and Short Term Investments | 0.025 | 40.6 | 15.7 |
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 0.087 | 45.3 | 18.4 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | — | 0.082 | 0.121 |
Net Intangible Assets | |||
Other Long Term Assets | |||
Total Assets | 0.087 | 51 | 22.9 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Current Liabilities | 0.063 | 4.73 | 13.5 |
Long Term Debt | |||
Total Long Term Debt | |||
Total Debt | |||
Total Liabilities | 0.063 | 14.2 | 23.8 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 0.023 | 36.7 | -0.899 |
Total Liabilities & Shareholders' Equity | 0.087 | 51 | 22.9 |
Total Common Shares Outstanding |